Knee / Knee Calcific Tendinitis / Shockwave / VAS+KOOS JR

This Circle helps physicians capture and monetize real-world data from their everyday delivery of Shockwave for Knee Calcific Tendinitis.

The Shockwave Market was valued at $1.34 Billion in 2023, and is estimated to grow to $2.4 Billion by 2030. Knee Calcific Tendinitis tends to occur more frequently in middle-aged adults, typically between the ages of 40 and 60, though it can affect individuals of any age. With global life expectancy increasing, manufacturers will increase spending to obtain regulatory approvals for marketing shockwave products. Increasingly, that spend will be focused on licensing real-world safety and efficacy data from their everyday customers.

This Circle helps physicians obtain and aggregate those high quality real-world data those companies are looking for. Participation is minimally burdensome, and members will receive recurring license fees once obtained and in accordance with their contribution of Knee Calcific Tendinitis cases, outcomes and other case data.